{"id":"nitrogen-nf","rwe":[],"_fda":{"id":"460169a7-56b6-ad4e-e063-6294a90ac25d","set_id":"1119f82c-0441-4c4f-8423-4518d0d1f060","openfda":{"unii":["N762921K75"],"route":["RESPIRATORY (INHALATION)"],"rxcui":["348987"],"spl_id":["460169a7-56b6-ad4e-e063-6294a90ac25d"],"brand_name":["NITROGEN NF"],"spl_set_id":["1119f82c-0441-4c4f-8423-4518d0d1f060"],"package_ndc":["42602-005-07","42602-005-08","42602-005-09","42602-005-10","42602-005-01","42602-005-02","42602-005-03","42602-005-04","42602-005-05","42602-005-06","42602-005-11"],"product_ndc":["42602-005"],"generic_name":["NITROGEN"],"product_type":["HUMAN PRESCRIPTION DRUG"],"substance_name":["NITROGEN"],"manufacturer_name":["Norco, Inc"],"application_number":["NDA205805"],"is_original_packager":[true]},"version":"13","effective_time":"20251215","other_safety_information":["NITROGEN NF COA N2 NF CoA Norco_COA_n2"],"spl_product_data_elements":["NITROGEN NF NITROGEN NITROGEN NITROGEN"],"package_label_principal_display_panel":["NITROGEN NF LIQUID LABEL REFRIGERATED LIQUID NITROGEN, REFRIGERATED LIQUID NF NON-FLAMMABLE GAS 2 UN1977 41977 (12/14) Rx only WARNING: Administration of Nitrogen may be hazardous or contraindicated. For use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of Nitrogen and is familiar with the indications, effects, dosages, methods, and frequency and duration of administration, and with the hazards, contraindications, and side effects and the precautions to be taken. WARNING: CONTAINS REFRIGERATED GAS: MAY CAUSE CRYOGENIC BURNS OR INJURY MAYDISPLACE OXYGEN AND CAUSE RAPID SUFFOCATION. Do not handle until all safety precautions have been read and understood. Use and store only outdoors or in a well- ventilated place. Wear cold insulating gloves. Face shield, and eye protection. Use a back flow preventive device in the piping. DO NOT change or force fit connections. Close valve after each use and when empty. Always keep container in upright position. Read and follow the Safety Data Sheet (SDS) before use. FIRST AID: IF INHALED: Remove person and keep comfortable for breathing. IF ON SKIN: Thaw frosted parts with lukewarm water. Do not rub affected area. Get immediate medical advice/attention. CAS: 7727-37-9 DO NOT REMOVE THIS PRODUCT LABEL NORCO 1125 W. Amity ● Boise, Idaho 83705 (208) 336-1643 USPUN1977 RES NF Liq UN1977","NITROGEN NF HP LABEL NITROGEN, COMPRESSED NF UN1066 NON-FLAMMABLE GAS 2 (R-K14) CONTENTS: LTRS: _____ CU. FT. _____ WARNING: Rx only. WARNING: Administration of Nitrogen may be hazardous or contraindicated. For use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of Nitrogen and is familiar with the indications, effects, dosages, methods, and frequency and duration of administration, and with the hazards, contraindications, and side effects and the precautions to be taken. WARNING CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED. MAY DISPLACE OXYGEN AND CAUSE RAPID SUFFOCATION. Do not handle until all safety precautions have been read and understood. Use and store only outdoors or in a well-ventilated place. Use a back flow preventive device in the piping. Use only with equipment rated for cylinder pressure. Close valve after each use and when empty. Protect from sunlight when ambient temperature exceeds 52 C (125 F). Read and follow the Safety Data Sheet (SDS) before use. FIRST AID: IF INHALED: Remove person and keep comfortable for breathing. Get Medical/advice/attention. CAS: 7727-37-9 DO NOT REMOVE THIS PRODUCT LABEL NORCO 1125 W. Amity Rd. Boise, Idaho 83705 (208) 336-1643 res UN1066 R-K14"]},"tags":[],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Congenital Heart Defect Requiring Open Patent Ductus Arteriosus","Left heart failure","Methemoglobinemia"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"approved","trials":["NCT02257567","NCT01401517","NCT03829566","NCT03342638","NCT03593902","NCT01415765","NCT01445405"],"aliases":[],"company":"UNIVERSAL INDUSTRIAL GASES, INC","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=NITROGEN, NF","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:48:32.373014+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:48:39.227620+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NITROGEN, NF","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:48:40.044808+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:48:30.126633+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:48:30.126694+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL142438/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:48:40.730052+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"NDA205805","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:48:30.126705+00:00"}},"offLabel":[],"timeline":[],"brandName":"NITROGEN, NF","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small Molecule","drugClass":"","explanation":"","oneSentence":""},"commercial":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:48:42.619156+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://www.fda.gov/drugs","name":"FDA Drugs@FDA","fields":["phase","status","brandName","company"],"retrievedDate":"2026-04-07"},{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"NITROGEN, NF","indications":{"approved":[{"name":"Persistent pulmonary hypertension of the newborn","diseaseId":"persistent-pulmonary-hypertension-of-the-newborn","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"currentOwner":"UNIVERSAL INDUSTRIAL GASES, INC","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02257567","phase":"Phase 1","title":"A Phase IB/II Study Evaluating The Safety, Tolerability and Anti-Tumor Activity of Polatuzumab Vedotin in Combination With Rituximab (R) or Obinutuzumab (G) Plus Bendamustine (B) in Relapsed or Refrac","status":"COMPLETED","sponsor":"Hoffmann-La Roche","isPivotal":false,"enrollment":331,"indication":"Lymphoma","completionDate":"2021-10-21"},{"nctId":"NCT01401517","phase":"Phase 2","title":"A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral ","status":"COMPLETED","sponsor":"TheraVasc Inc.","isPivotal":false,"enrollment":55,"indication":"Peripheral Arterial Disease","completionDate":"2013-01"},{"nctId":"NCT03829566","phase":"Phase 2","title":"Autologous Hematopoietic Stem Cell Transplant for Neuromyelitis Optica Spectrum Disorder (NMOSD)","status":"WITHDRAWN","sponsor":"Northwestern University","isPivotal":true,"enrollment":0,"indication":"Neuromyelitis Optica, Devic's Disease","completionDate":"2025-11-28"},{"nctId":"NCT03342638","phase":"Phase 3","title":"Maximizing Outcome of Multiple Sclerosis Transplantation: \"MOST\" Trial","status":"TERMINATED","sponsor":"Northwestern University","isPivotal":true,"enrollment":66,"indication":"Multiple Sclerosis, Relapsing-Remitting","completionDate":"2019-10-09"},{"nctId":"NCT03593902","phase":"Phase 2","title":"Autologous Hematopoietic Stem Cell Transplant for Patients With Systemic Sclerosis and Cardiac Dysfunction","status":"TERMINATED","sponsor":"Northwestern University","isPivotal":true,"enrollment":9,"indication":"Systemic Sclerosis, Scleroderma","completionDate":"2019-10-09"},{"nctId":"NCT01415765","phase":"Phase 1","title":"Phase I/II Study of MLN4924 Alone Followed by Dose-Adjusted EPOCH-Rituximab + MLN4924 With Gene Expression Profiling and Mutational Analysis in Relapsed/Refractory de Novo Diffuse Large B-Cell Lymphom","status":"WITHDRAWN","sponsor":"National Cancer Institute (NCI)","isPivotal":false,"enrollment":0,"indication":"Lymphoma, Diffuse Large-Cell B-cell, Diffuse, Large B-cell Lymphoma","completionDate":"2014-01-07"},{"nctId":"NCT01445405","phase":"Phase 1","title":"Phase I Study of Bortezomib and Cetuximab Without or With Cisplatin in Combination With Radiation Therapy for Advanced Head and Neck Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","isPivotal":false,"enrollment":3,"indication":"Carcinoma, Squamous, Head and Neck Cancer","completionDate":"2010-08-27"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"Respiratory (Inhalation)","frequency":"","formulation":""},"crossReferences":{"chemblId":"CHEMBL142438"},"formularyStatus":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"companyName":"UNIVERSAL INDUSTRIAL GASES, INC","companyId":"universal-industrial-gases-inc","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-06-23T00:00:00.000Z","mah":"AIR LIQUIDE LARGE INDUSTRIES US LP","brand_name_local":"NITROGEN, NF","application_number":"NDA205738"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-07-05T00:00:00.000Z","mah":"LINDE GAS PUERTO RICO INC","brand_name_local":"NITROGEN, NF","application_number":"NDA205816"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-07-05T00:00:00.000Z","mah":"LINDE NORTH AMERICA INC","brand_name_local":"NITROGEN, NF","application_number":"NDA205766"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-07-14T00:00:00.000Z","mah":"NORCO INC","brand_name_local":"NITROGEN, NF","application_number":"NDA205805"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-07-23T00:00:00.000Z","mah":"AIR PRODUCTS AND CHEMICALS INC","brand_name_local":"NITROGEN, NF","application_number":"NDA205866"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-07-23T00:00:00.000Z","mah":"ASPEN AIR","brand_name_local":"NITROGEN, NF","application_number":"NDA205863"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-08-02T00:00:00.000Z","mah":"MATHESON TRI-GAS INC","brand_name_local":"NITROGEN, NF","application_number":"NDA205891"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-08-27T00:00:00.000Z","mah":"PRAXAIR CANADA INC","brand_name_local":"NITROGEN, NF","application_number":"NDA205985"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-09-07T00:00:00.000Z","mah":"AIRGAS USA LLC","brand_name_local":"NITROGEN, NF","application_number":"NDA206024"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2018-04-09T00:00:00.000Z","mah":"CRISTAL ASU LLC","brand_name_local":"NITROGEN, NF","application_number":"NDA211737"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2020-06-29T00:00:00.000Z","mah":"AIR LIQUIDE CANADA INC","brand_name_local":"Nitrogen, NF","application_number":"NDA214858"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2022-06-10T00:00:00.000Z","mah":"ABSOLUTE AIR, LLC","brand_name_local":"Nitrogen, NF","application_number":"NDA217499"},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:48:42.619156+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}